In the current study, we show that ovarian cancers expressing low levels of Caspase 8 may be resistant to standard apoptotic-inducing chemotherapy treatments, because they exhibit poorer prognosis than ovarian cancers expressing high Caspase 8 levels. The gene discussed is CASP8; the disease is ovarian cancer.